Plasma-mediated transfection of RPE

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6138, Issue , 2006, Pages

  Palanker, D ^a,b   Chalberg, T ^a   Vankov, A ^a,b   Huie, P ^a,b   Molnar, F E ^a   Butterwick, A ^b   Calos, M ^a   Marmor, M ^a   Blumenkranz, M S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Cavitation; Electroporation; Gene therapy; RPE

Indexed keywords

EFFICIENT TRANSFECTION; ELECTROPORATION; IN-VIVO EXPERIMENTS; OCULAR GENE THERAPY;

BIOLUMINESCENCE; CAVITATION; DNA; ELECTRIC CONDUCTIVITY; ELECTRIC CURRENT CARRYING CAPACITY (CABLES); ELECTRIC DISCHARGES; EYE PROTECTION; IMMUNOLOGY; MOLECULAR BIOLOGY; PATIENT TREATMENT; TISSUE;

GENETIC ENGINEERING;

EID: 33745352011     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.649624     Document Type: Conference Paper

References (40)

1. Bennett J. Gene therapy for retinitis pigmentosa. Curr Opin Mol Ther. 2000;2:420-425.
2. Ali RR, Sarra GM, Stephens C, et al. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet. 2000;25:306-310.
3. Schlichtenbrede FC, da Cruz L, Stephens C, et al. Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy. J Gene Med. 2003;5:757-764.
4. Bennett J, Tanabe T, Sun D, et al. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat Med. 1996;2:649-654.
5. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
6. Narfstrom K, Bragadottir R, Redmond TM, Rakoczy PE, van Veen T, Bruun A. Functional and structural evaluation after AAV.RPE65 gene transfer in the canine model of Leber's congenital amaurosis. Adv Exp Med Biol. 2003;533:423-430.
7. Vollrath D, Feng W, Duncan JL, et al. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc Natl Acad Sci USA. 2001;98:12584-12589.
8. Kootstra NA, Verma IM. Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol. 2003;43:413-439.
9. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-XI. Science. 2003;302:415-419.
10. Nicolazzi C, Garinot M, Mignet N, Scherman D, Bessodes M. Cationic lipids for transfection. Curr Med Chem. 2003;10:1263-1277.
11. Andre F, Mir LM. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther. 2004;11 Suppl 1:S33-42.
12. Liang HD, Lu QL, Xue SA, et al. Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med Biol. 2004;30:1523-1529.
13. Somiari S, Glasspool-Malone J, Drabick JJ, et al. Theory and in vivo application of electroporative gene delivery. Mol Ther. 2000;2:178-187.
14. Pliquett UF, Martin GT, Weaver JC. Kinetics of the temperature rise within human stratum corneum during electroporation and pulsed high-voltage iontophoresis. Bioelectrochemistry. 2002;57:65-72.
15. Lenz P, Bacot SM, Frazier-Jessen MR, Feldman GM. Nucleoporation of dendritic cells: efficient gene transfer by electroporation into human monocyte-derived dendritic cells. FEES Lett. 2003;538:149-154.
16. Fechheimer M, Boylan JF, Parker S, Sisken JE, Patel GL, Zimmer SG. Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proc Natl Acad Sci USA. 1987;84:8463-8467.
17. Guzman HR, Nguyen DX, Khan S, Prausnitz MR. Ultrasound-mediated disruption of cell membranes. I. Quantification of molecular uptake and cell viability. J Acoust Soc Am. 2001;110:588-596.
18. Guzman HR, Nguyen DX, Khan S, Prausnitz MR. Ultrasound-mediated disruption of cell membranes. II. Heterogeneous effects on cells. J Acoust Soc Am. 2001;110:597-606.
19. Miller DL, Gies RA. Enhancement of ultrasonically-induced hemolysis by perfluorocarbon-based compared to air-based echo-contrast agents. Ultrasound Med Biol. 1998;24:285-292.
20. Harrison GH, Balcer-Kubiczek EK, Gutierrez PL. In vitro mechanisms of chemopotentiation by tone-burst ultrasound. Ultrasound Med Biol. 1996;22:355-362.
21. Liu J, Lewis TN, Prausnitz MR. Non-invasive assessment and control of ultrasound-mediated membrane permeabilization. Pharm Res. 1998;15:918-924.
22. Tieleman DP, Leontiadou H, Mark AE, Marrink SJ. Simulation of pore formation in lipid bilayers by mechanical stress and electric fields. J Am Chem Soc. 2003;125:6382-6383.
23. Chalberg TW, Genise HL, Vollrath D, Calos MP. phiC31 integrase confers genomic integration and long-term transgene expression in rat retina. Invest Ophthalmol Vis Sci. 2005;46:2140-2146.
24. Thyagarajan B, Calos MP. Site-specific integration for high-level protein production in mammalian cells. Methods Mol Biol. 2005;308:99-106.
25. Marc RE, Murry RF, Fisher SK, Linberg KA, Lewis GP, Kalloniatis M. Amino acid signatures in the normal cat retina. Invest Ophthalmol Vis Sci. 1998;39:1685-1693.
26. Bennett J, Maguire AM, Cideciyan AV, et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci USA. 1999;96:9920-9925.
27. Leng T, Miller JM, Bilbao KV, Palanker DV, Huie P, Blumenkranz MS. The chick chorioallantoic membrane as a model tissue for surgical retinal research and simulation. Retina. 2004;24:427-434.
28. Miller JM, Palanker DV, Vankov A, Marmor MF, Blumenkranz MS. Precision and safety of the pulsed electron avalanche knife in vitreoretinal surgery. Arch Ophthalmol. 2003;121:871-877.
29. Palanker D, Vankov A, Bilbao K, Marmor M, Blumenkranz M. Optimization of the pulsed electron avalanche knife for anterior segment surgery. Proceedings of the SPIE - The International Society for Optical Engineering. 2003;4951:56-61.
30. Palanker DV, Marmor MF, Branco A, et al. Effects of the pulsed electron avalanche knife on retinal tissue. Arch Ophthalmol. 2002;120:636-640.
31. Palanker DV, Miller JM, Marmor MF, Sanislo SR, Huie P, Blumenkranz MS. Pulsed electron avalanche knife (PEAK) for intraocular surgery. Invest Ophthalmol Vis Sci. 2001;42:2673-2678.
32. Gjorloff K, Andreasson S, Ehinger B. Standardized full-field electroretinography in rabbits. Doc Ophthalmol. 2004;109:163-168.
33. Matsuda T, Cepko CL. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc Natl Acad Sci USA. 2004;101:16-22.
34. Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP. Site-specific genomic integration in mammalian cells mediated by phage fC31 integrase. Mol Cell Biol. 2001;21:3926-3934.
35. Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP. Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol. 2002;20:1124-1128.
36. Ortiz-Urda S, Thyagarajan B, Keene DR, et al. Stable nonviral genetic correction of inherited human skin disease. Nat Med. 2002;8:1166-1170.
37. Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Calos MP, Khavari PA. PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum Gene Ther. 2003;14:923-928.
38. Quenneville SP, Chapdelaine P, Rousseau J, et al. Nucleofection of muscle-derived stem cells and myoblasts with fC31 integrase: stable expression of a fiill-length-dystrophin fusion gene by human myoblasts. Mol Ther. 2004; 10:679-687.
39. Hollis RP, Stoll SM, Sclimenti CR, Lin J, Chen-Tsai Y, Calos MP. Phage integrases for the construction and manipulation of transgenic mammals. Reprod Biol Endocrinol. 2003;1:79.
40. Groth AC, Fish M, Nusse R, Calos MP. Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. Genetics. 2004;166:1775-1782.